))
How to commercialise research – NHS perspective
Manage episode 340538526 series 3304973
Treść dostarczona przez Connect: Health Tech. Cała zawartość podcastów, w tym odcinki, grafika i opisy podcastów, jest przesyłana i udostępniana bezpośrednio przez Connect: Health Tech lub jego partnera na platformie podcastów. Jeśli uważasz, że ktoś wykorzystuje Twoje dzieło chronione prawem autorskim bez Twojej zgody, możesz postępować zgodnie z procedurą opisaną tutaj https://pl.player.fm/legal.
In this episode we explore research commercialisation from an NHS perspective. Navigating the NHS healthcare system can be a daunting prospect for an innovator. Dr Louise Jopling, Commercial Director at the Eastern Academic Health Science Network, explains the routes available for those to looking to have their technology adopted into the NHS.
Louise leads the commercial team at EAHSN to develop partnerships and support innovators to refine their business models and value propositions to ensure commercial sustainability.
Louise holds a PhD in immunology from Imperial College London and drawing on both her background in science and years of experience in drug discovery, development and commercialisation within academia, biotech and pharmaceutical organisations, she leads the commercial team to develop partnerships and support innovators to refine their business models and value propositions to ensure commercial sustainability.
Louise joined Eastern AHSN from Johnson and Johnson Innovation, where she led partnership activities across Europe, Middle East and Africa to identify and incubate external assets and capabilities to advance the portfolio of the Immunology Therapy Area for Janssen.
Louise is an advisory board member for MedTech Integrates conference, a mentor on a number of accelerator programmes including Accelerate Cambridge (Judge Business School) and Start Codon. She is also a long-standing member of the British Society for Immunology.
16 odcinków
Udostępnij
